Is MELD score failing patients with liver disease and hepatorenal syndrome?

作     者：Lena Sibulesky Nicolae Leca Christopher Blosser Amir A Rahnemai-Azar Renuka Bhattacharya Jorge Reyes 

作者机构：Department of SurgeryDivision of Transplant SurgeryUniversity of Washington Department of MedicineDivision of NephrologyUniversity of Washington Department of MedicineDivision of GastroenterologyUniversity of Washington 

出 版 物：《World Journal of Hepatology》 (世界肝病学杂志（英文版）（电子版）)

年 卷 期：2016年第8卷第27期

页      面：1155-1156页

学科分类：1002[医学-临床医学] 100210[医学-外科学(含：普外、骨外、泌尿外、胸心外、神外、整形、烧伤、野战外)] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

主　　题：MELD Hepatorenal syndrome Cirrhosis Graft survival Liver allocation 

摘      要：There is a need to reassess the application of MELD and the impact of renal insufficiency with consideration for developing an algorithm with exception points that would lead to timely allocation of livers to patients with hepatorenal syndrome prior to occurrence of permanent renal damage without jeopardizing post-transplant survival.